USC President C. L. Max Nikias (center) congratulates Presidential Medallion honorees USC Trustee Verna B. Dauterive (left) and Inderbir Gill of the Keck School of Medicine of USC.
By USC Health Sciences Public Relations and Marketing
Inderbir Gill, chairman and professor of the Catherine and Joseph Aresty Department of Urology and founding executive director of the USC Institute of Urology, has received the Presidential Medallion, USC’s highest honor.
USC President C.L. Max Nikias presented Gill with the award at the 32nd annual Academic Honors Convocation on April 23.
The medallion, which was also presented to USC Trustee Verna B Dauterive, is awarded to those who have brought honor and distinction to the university.
In his introduction, Nikias noted Gill’s contributions to robotic and laparoscopic surgery, and called Gill a “world leader” in minimally invasive kidney-preserving surgery for renal cancer.
“Dr. Gill is a true medical visionary who has immeasurably advanced USC’s clinical experience, while reimagining the boundaries of modern surgery,” Nikias said.
Gill, who also serves as associate dean of clinical innovation at the Keck School of Medicine of USC, is ranked as the top author in the entire field of urology, having published eight textbooks and 513 peer-reviewed scientific papers with more than 8,000 citations.
Nikias also recognized the recent appointment of Jae Jung as a distinguished professor. Jung, who was appointed in February, holds the Fletcher Jones Foundation Distinguished Chair in Molecular Biology and Immunology at the Keck School. He also holds a joint appointment in pharmacology and pharmaceutical sciences at the USC School of Pharmacy.
Other awards and winners included:
• Associates Award for Creativity in Research and Scholarship was presented to Yves De Clerck, professor of pediatrics, biochemistry and molecular biology;
• Phi Kappa Phi Faculty Recognition Award was given to Gelya Frank, professor of occupational therapy and anthropology;
• Phi Kappa Phi Student Recognition Award was presented to Shili Xu, candidate: Ph.D. pharmacology and pharmaceutical sciences at the USC School of Pharmacy.